November 28, 2016 - By Michael Collier
A calculated and well-grounded move was made by the CMSO of Mesa Laboratories Inc Co, Mr. Glenn Adriance, yesterday, when he unloaded number of shares – 3,567, amounting to $484,862 U.S Dollars, based on an avg price of $135.9 for each one share. Today, Glenn Adriance owns 14,100 shares which are exactly 0.39% of Mesa Laboratories Inc Co’s market capitalization. These shares were unloaded on November 28, 2016 and the filing that contains the original information, filed with the Washington-based Security and Exchange Commission can be accessed here.
Insitutional Activity: The institutional sentiment decreased to 1.46 in Q2 2016. Its down 0.68, from 2.14 in 2016Q1. The ratio dropped, as 5 funds sold all Mesa Laboratories, Inc. shares owned while 16 reduced positions. 15 funds bought stakes while 30 increased positions. They now own 1.99 million shares or 2.18% less from 2.04 million shares in 2016Q1.
Creative Planning accumulated 0% or 350 shares. Aqr Cap Ltd holds 0% of its portfolio in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 2,917 shares. Conestoga Cap Advisors Lc holds 3.18% or 350,454 shares in its portfolio. Tiaa Cref Mngmt Llc holds 0% of its portfolio in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 9,280 shares. Quantbot Technology Ltd Partnership last reported 55 shares in the company. Keybank National Association Oh accumulated 0% or 4,700 shares. Westpac Bk Corporation holds 5,054 shares or 0% of its portfolio. Moreover, Bankshares Of New York Mellon Corporation has 0% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 15,221 shares. State Common Retirement Fund holds 3,400 shares or 0% of its portfolio. Glenmede Tru Na accumulated 0% or 1,175 shares. King Luther Corporation has invested 0.01% of its portfolio in Mesa Laboratories, Inc. (NASDAQ:MLAB). Metropolitan Life Ins Communications New York holds 0% of its portfolio in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 2,256 shares. California State Teachers Retirement Sys accumulated 6,292 shares or 0% of the stock. Northern Tru Corp last reported 0% of its portfolio in the stock. Wasatch Advsr has 0.07% invested in the company for 35,685 shares.
Insider Transactions: Since June 6, 2016, the stock had 0 buys, and 4 selling transactions for $1.28 million net activity. $335,220 worth of Mesa Laboratories, Inc. (NASDAQ:MLAB) shares were sold by Adriance Glenn E. Shares for $476,080 were sold by CAMPBELL H STUART on Friday, October 21. $127,140 worth of Mesa Laboratories, Inc. (NASDAQ:MLAB) was sold by Sakys John.
About 3,201 shares traded hands. Mesa Laboratories, Inc. (NASDAQ:MLAB) has risen 36.15% since April 25, 2016 and is uptrending. It has outperformed by 30.14% the S&P500.
Mesa Laboratories, Inc. is focused primarily on quality control services and products. The company has a market cap of $467.76 million. The Firm operates through four divisions: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. It has a 43.5 P/E ratio. The Instruments Division designs, makes and markets quality control instruments and disposable products.
According to Zacks Investment Research, “MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.”
Analysts await Mesa Laboratories, Inc. (NASDAQ:MLAB) to report earnings on February, 7. They expect $0.88 earnings per share, down 4.35% or $0.04 from last year’s $0.92 per share. MLAB’s profit will be $3.17M for 36.93 P/E if the $0.88 EPS becomes a reality. After $0.92 actual earnings per share reported by Mesa Laboratories, Inc. for the previous quarter, Wall Street now forecasts -4.35% negative EPS growth.
More important recent Mesa Laboratories, Inc. (NASDAQ:MLAB) news were published by: Marketwatch.com which released: “Mesa Laboratories downgraded to neutral from buy at Sidoti & Co.” on April 21, 2011, also Streetinsider.com published article titled: “Form 4 MESA LABORATORIES INC For: Nov 23 Filed by: Adriance Glenn E”, Quotes.Wsj.com published: “News Mesa Laboratories Inc.MLAB” on February 11, 2011. More interesting news about Mesa Laboratories, Inc. (NASDAQ:MLAB) was released by: Nasdaq.com and their article: “Mesa Laboratories, Inc. (MLAB) Ex-Dividend Date Scheduled for November 28, 2016” with publication date: November 25, 2016.
Mesa Laboratories, Inc., incorporated on March 26, 1982, is focused primarily on quality control services and products. The Firm operates through four divisions: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, makes and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling and semiconductor industries. The Company’s Biological Indicators Division provides testing services, along with the manufacturing and marketing of biological indicators and distribution of chemical indicators used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide and radiation, in the hospital, dental, medical device and pharmaceutical industries. The Company’s Continuous Monitoring Division designs, develops and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity and differential pressure in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies and various other laboratory and industrial environments. The Company’s Cold Chain Division provides parameter (primarily temperature) monitoring of products in a cold chain, consulting services, such as compliance monitoring, packaging development and validation or mapping of transport and storage containers, and thermal packaging products, such as coolers, boxes, insulation materials and phase-change products to control temperature during transport.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.